ARCHIVES

Cancer Research Institute Goes To Wall Street

This article is from The Cancer Letter archive.

Vol. 12 No. 03 | January 17, 1986

Download PDF Visit The Full Archive

Related Articles

Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research

December 15, 1995

Recompetition of $1.9 Mil. Primate Contract Approved

November 15, 1985

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

September 22, 1995

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013